Immunization

Investigators determined that the vaccination reduced the prevalence of vaccine serotypes with an effectiveness of 89.6% based on the study results.

Investing in community relationships and health literacy are key steps pharmacists can take to improve equity.

Despite the growth in vaccine and antibody development for combatting RSV, lower income countries may not reap the benefits.

The findings suggest that 6 months after vaccination with ARCT-154, individuals had a longer immune response.

Investigators found high incidences of non-susceptibility with penicillin and increasing resistance to macrolides for pneumococcal diseases.

The 23-valent pneumococcal polysaccharide vaccine was most likely associated with a higher risk of immunological events for those who were immunocompromised, but the events were low.

Addressing complacency, confidence, and convenience are all crucial to increasing vaccine uptake.

Older adults without a Part D plan face costs ranging from $180 to $295 per shot.

Infection-induced immunity with 2-dose vaccination still offered protection against the circulating variant.

The schedule includes RSV vaccination, along with updated versions of the COVID-19 vaccine.

Despite Travis Kelce’s recent commercial with Pfizer, data show celebrity endorsements do not convince listeners to receive immunizations

Individuals with PCV20-serotype disease were generally younger compared to those who had PCV13 serotype community-acquired pneumonia.

According to the study investigators, findings indicat that pneumococcal vaccination in older adults and other interventions should be considered for reducing the disease burden.

Stress may have more of an effect on migraines than COVID-19 infection or vaccination.

If vaccination coverage was increased by 100%, outpatient care could be reduced by 81.2%, hospitalizations by 91.7%, and deaths by 91.3%.

Investigators optimized the assay during development and qualification to be used in the clinical setting for pneumococcal conjugate vaccines.

The study highlights the ongoing need for health care providers to recommend respiratory illness vaccinations to increase protection among nursing home residents during the peak season of infection.

However, comprehensive policy and payment structures are needed to ensure care sustainability.

The study results also determined that those who were previously vaccinated against smallpox had a 2.7 times higher immune response than those who were not previously vaccinated.

The SHARE model from the CDC involves personalizing recommendations for patients and their needs, addressing any concerns they may have, and explaining the risks of remaining unvaccinated.

The study authors note that the findings could be significant in future HIV vaccine design and development, as well as new approaches to HIV immunotherapy.

Investigators aim to find a substitution for incomplete Freund adjuvant, which is not suitable for use in humans but shows a strong response to antigen-specific systemic immune responses.

If approved, V116 would offer significant improvements in safety and effectiveness for the prevention of pneumococcal disease.

The study, which consists of 3 trials, will continue with oral PrEP regimens; however, the vaccination trials have stopped due to the unlikely chance of the vaccine showing efficacy.

The proposed Vaccine Injury Compensation Modernization Act is intended to bring valuable updates to the 36-year-old legislation.

Out of the 600 infants, 169 were born prematurely, 487 did not have underlying medical conditions, and 143 had to receive invasive mechanical ventilation.

The results found that the M2e nanoparticle injection could efficiently protect individuals from influenza A viruses.

Clinical trial results show the immunogenicity, tolerability, and safety of V116 compared to a pneumococcal 20-valent conjugate vaccine for adults who had not previously received a pneumococcal vaccine.

Fractional COVID-19 dosing resulted in fewer adverse effects and costs while producing similar immune responses compared to a full dose vaccine.

Prefilled diluent and vaccine syringes may be easily mixed up